case_images: PMC10601834_01
case_images: Spectral domain OCT imaging revealing bilateral CME during the initial visit to the ophthalmologist (right side (a), left side (b)). Improvement in the bilateral CME is observed 2 months following cessation of chemotherapy treatment (right side (c), left side (d)).
case_images: cro-2023-0016-0001-533999_F01.jpg
case_images: PMC10601834_01_cro-2023-0016-0001-533999_F01.jpg
case_images: F1
case_images: Optical coherence tomography (OCT) confirmed bilateral edema in the macula (Fig. 1a, b). Therefore, in collaboration with our hospital and ophthalmologist, treatment with Nab-PTX and atezolizumab were ceased 20 months after the start of chemotherapy. Two months later, the patient's visual symptoms had improved (right 0.06; left 0.08), as did the bilateral CME as observed on OCT (Fig. 1c, d).